PepsiCo (PEP) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
9 Jul, 2026Executive summary
Net revenue grew 7% in the first half of 2026, reaching $43.6B, with global volumes up 3% in foods and 2% in beverages, marking the fastest volume growth since 2022.
EPS increased 6% on a reported basis and surged 72% year-to-date, reflecting prior-year impairment charges and operating profit growth.
Operating profit rose 65% for the half-year, driven by productivity initiatives, lower restructuring costs, and lapping prior-year impairments.
U.S. foods business returned to volume growth and gained share, while international business remained a key growth driver with strong performance across regions.
Company reaffirmed 2026 guidance, focusing on top-line growth, innovation, and productivity.
Financial highlights
Net revenue for the half-year was $43.6B, up 7% year-over-year; Q2 net revenue was $24.2B, up 6.4%.
Operating profit for the half-year was $7.2B, up 65%; Q2 operating profit was $4.0B, up 125%.
Gross profit reached $23.8B for the half-year, with gross margin at 54.6%.
Free cash flow for the half-year was $1.17B, up from negative $342M a year ago.
Cash and cash equivalents at period end were $10.3B.
Outlook and guidance
Full-year guidance reaffirmed, with organic revenue growth expected between 2–4% and core constant currency EPS growth of 4–6%.
Total cash returns to shareholders projected at $8.9B in 2026, including $7.9B in dividends and $1B in share repurchases.
Tariff refund claims to contribute about 1 point of EPS growth for the year, helping offset commodity inflation.
Capital spending to remain below 5% of net revenue; free cash flow conversion ratio at least 80%.
Continued focus on productivity and increased marketing investment in North America in the second half.
Latest events from PepsiCo
- Strong global growth, portfolio innovation, and digital transformation drive future strategy.PEP
Consumer Analyst Group of New York Conference (CAGNY ) 20258 Jul 2026 - Net revenue up 8.5%-9%, EPS up 27%, with 2026 guidance and dividend hike reaffirmed.PEP
Q1 20265 Jun 2026 - Board refreshment, strategic growth, and a 4% dividend increase highlighted; all management proposals passed.PEP
AGM 202612 May 2026 - Board recommends FOR all company proposals and AGAINST all shareholder proposals.PEP
Proxy filing27 Mar 2026 - Annual meeting covers director elections, auditor ratification, and key ESG proposals.PEP
Proxy filing27 Mar 2026 - $94B revenue, health-driven innovation, and global expansion drive growth and margin targets.PEP
Consumer Analyst Group of New York Conference (CAGNY) 202618 Feb 2026 - Q1 2025: revenue, income, and EPS down; guidance cut; dividend up 5%; acquisitions ongoing.PEP
Q1 20253 Feb 2026 - Affordability, innovation, and strong Q4 results drive growth and higher dividends in 2026.PEP
Q4 20253 Feb 2026 - Q2 2024 delivered strong EPS and margin gains, but Quaker recall and guidance cut weighed.PEP
Q2 20243 Feb 2026